# Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder

> **NCT00158028** · NA · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 25 (actual)

## Conditions studied

- Schizotypal Personality Disorder

## Interventions

- **DRUG:** Risperidone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00158028
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-11
- **Primary completion:** 2001-12
- **Final completion:** 2001-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00158028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00158028, "Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00158028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*